Drug Database
N04BA02 levodopa and decarboxylase inhibitor
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Apodespan PR 50/200 mg Prolonged-release Tablets
- POM Carbidopa/Levodopa Orion 12.5 mg/50 mg tablets
- POM Carbidopa/Levodopa Orion 25 mg/100 mg tablets
- POM Duodopa intestinal gel
- POM Lecado 100/25 mg Modified-release Tablets
- POM Lecado 200/50 mg Modified-release Tablets
- POM Madopar 100 mg/25 mg Dispersible Tablets
- POM Madopar 100mg/25mg Hard Capsules
- POM Madopar 200mg/50mg Hard Capsules
- POM Madopar 50 mg/12.5 mg Dispersible Tablets
- POM Madopar 50 mg/12.5 mg Hard Capsules
- POM Madopar CR 100 mg/25 mg Prolonged Release Hard Capsules
- POM Sinemet 12.5mg/50mg, 10mg/100mg, 25mg/100mg and 25mg/250mg Tablets
- POM Sinemet CR and Half Sinemet CR
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).